快速抗原检测 SARS-CoV-2 的假阳性结果。
False-Positive Results in Rapid Antigen Tests for SARS-CoV-2.
机构信息
University of Toronto, Toronto, Ontario, Canada.
Creative Destruction Lab, Toronto, Ontario, Canada.
出版信息
JAMA. 2022 Feb 1;327(5):485-486. doi: 10.1001/jama.2021.24355.
Abstract
This study examines the incidence of false-positive results in a sample of rapid antigen tests used to serially screen asymptomatic workers throughout Canada.
摘要
本研究调查了在加拿大对无症状工作人员进行连续筛查的快速抗原检测样本中假阳性结果的发生率。
相似文献
1
False-Positive Results in Rapid Antigen Tests for SARS-CoV-2.快速抗原检测 SARS-CoV-2 的假阳性结果。
JAMA. 2022 Feb 1;327(5):485-486. doi: 10.1001/jama.2021.24355.
2
Rapid Antigen Tests for SARS-CoV-2-Reply.针对严重急性呼吸综合征冠状病毒2的快速抗原检测——回复
JAMA. 2022 May 17;327(19):1926. doi: 10.1001/jama.2022.4469.
3
False Positive Covid-19 Rapid Antigen Tests.新冠病毒快速抗原检测的假阳性结果
N Engl J Med. 2024 May 16;390(19):1835-1836. doi: 10.1056/NEJMc2403409.
4
False Positive Covid-19 Rapid Antigen Tests. Reply.新冠病毒快速抗原检测的假阳性。回复。
N Engl J Med. 2024 May 16;390(19):1836. doi: 10.1056/NEJMc2403409.
5
Rapid Antigen Tests for SARS-CoV-2.新型冠状病毒2019（SARS-CoV-2）快速抗原检测
JAMA. 2022 May 17;327(19):1925-1926. doi: 10.1001/jama.2022.4466.
6
Setting-specific variability of false-positive result rates with rapid testing for SARS-CoV-2 antigen.使用SARS-CoV-2抗原快速检测时假阳性结果率的特定环境变异性。
J Clin Virol. 2022 Apr;149:105132. doi: 10.1016/j.jcv.2022.105132. Epub 2022 Mar 14.
7
Persistent False Positive Covid-19 Rapid Antigen Tests.新冠病毒快速抗原检测持续出现假阳性结果。
N Engl J Med. 2024 Feb 22;390(8):764-765. doi: 10.1056/NEJMc2313517.
8
Performance Evaluation of Serial SARS-CoV-2 Rapid Antigen Testing During a Nursing Home Outbreak.养老院内爆发期间对连续 SARS-CoV-2 快速抗原检测的性能评估。
Ann Intern Med. 2021 Jul;174(7):945-951. doi: 10.7326/M21-0422. Epub 2021 Apr 27.
9
Evaluation of two rapid antigen tests to detect SARS-CoV-2 in a hospital setting.评价两种快速抗原检测在医院环境下检测 SARS-CoV-2 的效果。
Med Microbiol Immunol. 2021 Feb;210(1):65-72. doi: 10.1007/s00430-020-00698-8. Epub 2021 Jan 16.
10
False Positive Results in SARS-CoV-2 Serological Tests for Samples From Patients With Chronic Inflammatory Diseases.慢性炎症性疾病患者样本的 SARS-CoV-2 血清学检测中出现假阳性结果。
Front Immunol. 2021 May 3;12:666114. doi: 10.3389/fimmu.2021.666114. eCollection 2021.
引用本文的文献
1
Mental Health and Cognitive Outcomes in Patients Six Months After Testing Positive Compared with Matched Patients Testing Negative for COVID-19 in a Non-Hospitalized Sample: A Matched Retrospective Cohort Study.非住院样本中新冠病毒检测呈阳性患者与匹配的检测呈阴性患者六个月后的心理健康和认知结果：一项匹配的回顾性队列研究
Int J Environ Res Public Health. 2025 Aug 9;22(8):1249. doi: 10.3390/ijerph22081249.
2
Comparative Detection and Genetic Characterization of Feline Panleukopenia Virus in Bangladesh.孟加拉国猫泛白细胞减少症病毒的比较检测与基因特征分析
Vet Med Sci. 2025 Sep;11(5):e70594. doi: 10.1002/vms3.70594.
3
Development of a Fluorescent Rapid Test Sensing System for Influenza Virus.流感病毒荧光快速检测传感系统的研发
Micromachines (Basel). 2025 May 28;16(6):635. doi: 10.3390/mi16060635.
4
Use of high-resolution fluorescence in situ hybridization for fast and robust detection of SARS-CoV-2 RNAs.使用高分辨率荧光原位杂交技术快速、稳健检测 SARS-CoV-2 RNA。
Sci Rep. 2024 Sep 8;14(1):20906. doi: 10.1038/s41598-024-70980-9.
5
Taqman PACMAN: a simple molecular approach for positive rapid antigen test confirmation during periods of low prevalence.Taqman PACMAN：一种简单的分子方法，可在低流行期对快速抗原检测进行阳性确认。
Microbiol Spectr. 2024 May 2;12(5):e0407323. doi: 10.1128/spectrum.04073-23. Epub 2024 Apr 3.
6
Aptamers and Nanobodies as New Bioprobes for SARS-CoV-2 Diagnostic and Therapeutic System Applications.适体和纳米抗体作为 SARS-CoV-2 诊断和治疗系统应用的新型生物探针。
Biosensors (Basel). 2024 Mar 15;14(3):146. doi: 10.3390/bios14030146.
7
Fluorometric and Colorimetric Method for SARS-CoV-2 Detection Using Designed Aptamer Display Particles.基于设计适体展示粒子的用于 SARS-CoV-2 检测的荧光和比色法。
Biosensors (Basel). 2024 Feb 20;14(3):113. doi: 10.3390/bios14030113.
8
Persistent False Positive Covid-19 Rapid Antigen Tests.新冠病毒快速抗原检测持续出现假阳性结果。
N Engl J Med. 2024 Feb 22;390(8):764-765. doi: 10.1056/NEJMc2313517.
9
Integrating the results of at-home diagnostic testing with public health surveillance to better track COVID-19 and future public health threats.整合家庭诊断检测结果与公共卫生监测，以更好地追踪新冠病毒及未来的公共卫生威胁。
Lancet Reg Health Am. 2024 Feb 3;30:100680. doi: 10.1016/j.lana.2024.100680. eCollection 2024 Feb.
10
Model for Interpreting Discordant SARS-CoV-2 Diagnostic Test Results.用于解释不一致的 SARS-CoV-2 诊断测试结果的模型。
Emerg Infect Dis. 2024 Feb;30(2):388-391. doi: 10.3201/eid3002.230200. Epub 2024 Jan 12.
Zotero 插件